Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 2/2007

01-02-2007 | Case Report

Endobronchial stenting for respiratory complications in relapsing polychondritis

Authors: Ossama Abbas, Mirna Fares, Ghassan Jamaleddine, Thurayya Arayssi, Zahi Touma, Pierre Bou Khalil

Published in: Clinical Rheumatology | Issue 2/2007

Login to get access

Abstract

Relapsing polychondritis is characterized by recurrent inflammation and destruction of the cartilage and connective tissue. Respiratory complications are frequently severe during the course of the disease and usually signal a poor prognosis. We report a case of a 47-year-old man with known relapsing polychondritis who presented with bilateral narrowing of the airways complicated by refractory cavitary Pseudomonas aeruginosa pneumonia. Despite an aggressive antibiotic regimen, the patient’s pneumonia did not improve until bronchial stenting 4 months later.
Literature
1.
Sarodia B, Dasgupta A, Mehta A (1999) Management of airway manifestations of relapsing polychondritis case reports and review of literature. Chest 116:1669–1675PubMedCrossRef
2.
Michet CJ Jr, Mchenna CH, Luthra HS, O’Fallon WM (1986) Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med 104:74–78PubMed
3.
Tillie-Leblond I, Wallaert B et al (1998) Respiratory involvement in relapsing polychondritis: clinical, functional, endoscopic, and radiographic evaluations. Medicine 77(3):168–176PubMedCrossRef
4.
Trentham D, Le HL (1998) Relapsing polychondritis. Ann Intern Med 129:114–122PubMed
5.
McAdams LP, O’Hanlan MA, Bluestone R et al (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55:193–215CrossRef
6.
Damiani JM, Levine HL (1979) Relapsing polychondritis: report of ten cases. Laryngoscope 89:929–946PubMedCrossRef
7.
Faul J, Kee S, Rizk N (1999) Endobronchial stenting for severe airway obstruction in relapsing polychondritis. Chest 116:825–827PubMedCrossRef
8.
Dunne J, Sabanathan S (1994) Use of metallic stents in relapsing Polychondritis. Chest 105:864–867PubMed
9.
Miyazu Y, Miyazawa T et al (2003) Endobronchial ultrasonography in the diagnosis and treatment of relapsing polychondritis with tracheobronchial malacia. Chest 124:2393–2395PubMedCrossRef
Metadata
Title
Endobronchial stenting for respiratory complications in relapsing polychondritis
Authors
Ossama Abbas
Mirna Fares
Ghassan Jamaleddine
Thurayya Arayssi
Zahi Touma
Pierre Bou Khalil
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0137-6

Other articles of this Issue 2/2007

Clinical Rheumatology 2/2007 Go to the issue

Original article

Pulmonary involvement in ankylosing spondylitis

Case Report

Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis

Brief Report

Age-related decrease in the activity of collagenase in the femoral head in patients with hip osteoarthritis

Case Report

Juvenile rheumatoid arthritis and bronchiolitis obliterans organized pneumonia

Original Article

Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre

Case Report

Isolated eosinophilic mesenteric vasculitis with extensive thrombosis and splenic infarction in a 13-year-old boy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits